Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Oral Oncology|August 13, 2018
Frequent HPV-independent p16/INK4A overexpression in head and neck cancerMatt Lechner, Ankur R Chakravarthy, Vonn Walter, et al.Genome Medicine|May 31, 2013
Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumorsMatthias Lechner, Garrett M Frampton, Tim Fenton, et al.The Lancet. Oncology|May 19, 2022
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 studyMarjorie G Zauderer, Peter W Szlosarek, Sylvestre Le Moulec, et al.Trials|January 14, 2024
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancerHisham Mehanna, Piers Gaunt, Anthony Kong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)Siow Ming Lee, Mary Falzon, Fiona Blackhall, et al.The Lancet. Oncology|July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trialShahneen K Sandhu, William R Schelman, George Wilding, et al.Elife|December 23, 2022
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model developmentPaul R Barber, Rami Mustapha, Fabian Flores-Borja, et al.Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.Nature|July 17, 2020
The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.Acta Neuropathologica|August 11, 2018
Correction to: DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.Pageof 10